#prep

#prep

I'm certainly confident that we're going to have a breakthrough within my career, and I have a good 10 to 15 years left. While antiretroviral (ARV) therapies are extending lives and keeping HIV at bay, and PrEP has the potential to effectively halt transmission of the virus, a cure has remained elusive. That's because the HIV virus itself is elusive, both co-opting the immune system and hiding from it.

Complementary research conducted mostly with cisgender sexual minority men suggests that those who are high on anxious attachment-those most worried that people will not love them or find them good enough-are generally more likely to have anal sex without using a condom (Starks et al., 2017; Starks & Parsons, 2014). In other words, guys who are worried that a boyfriend or partner will think they are not good enough are more likely to agree to have sex "bareback."

In the final episode of When We All Get to Heaven, we catch up on what's happened in the many years between the emergence of effective treatment for AIDS in the late '90s and the fall of 2025, when we recorded this episode. We linger on a moment back in June 1999, when Jim was still pastor and called on the church to remember that AIDS wasn't over. Because-advances notwithstanding-it still isn't over.

"We believe that easy access to PrEP medications is critical for Americans who may be exposed to HIV," Gourdine wrote. "Our formularies cover several PrEP options, both injectable and oral. For drugs excluded from our standard formularies, exceptions are available when medically justified."